{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:20:54Z","timestamp":1792682454448,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12951-017-0262-9","type":"journal-article","created":{"date-parts":[[2017,4,10]],"date-time":"2017-04-10T23:25:31Z","timestamp":1491866731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Imipenem\/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates"],"prefix":"10.1186","volume":"15","author":[{"given":"Mona I.","family":"Shaaban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma M.","family":"Mady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,11]]},"reference":[{"key":"262_CR1","first-page":"277","volume":"40","author":"CL Ventola","year":"2015","unstructured":"Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharm Ther. 2015;40:277\u201383.","journal-title":"Pharm Ther"},{"key":"262_CR2","first-page":"25","volume":"6","author":"RJ Fair","year":"2014","unstructured":"Fair RJ, Tor Y. Antibiotics and bacterial resistance in the 21st century. Perspect Med Chem. 2014;6:25\u201364.","journal-title":"Perspect Med Chem"},{"key":"262_CR3","doi-asserted-by":"crossref","first-page":"662","DOI":"10.7164\/antibiotics.29.662","volume":"29","author":"G Masuda","year":"1976","unstructured":"Masuda G, Tomioka S, Hasegawa M. Detection of beta-lactamase production by gram-negative bacteria. J Antibiot (Tokyo). 1976;29:662\u20134.","journal-title":"J Antibiot (Tokyo)"},{"key":"262_CR4","doi-asserted-by":"crossref","first-page":"246012","DOI":"10.1155\/2015\/246012","volume":"2015","author":"N Beyth","year":"2015","unstructured":"Beyth N, Houri-Haddad Y, Domb A, Khan W, Hazan R. Alternative antimicrobial approach: nano-antimicrobial materials. Evid Based Complement Alternat Med. 2015;2015:246012.","journal-title":"Evid Based Complement Alternat Med"},{"key":"262_CR5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.addr.2014.10.027","volume":"78","author":"BD Brooks","year":"2014","unstructured":"Brooks BD, Brooks AE. Therapeutic strategies to combat antibiotic resistance. Adv Drug Deliv Rev. 2014;78:14\u201327.","journal-title":"Adv Drug Deliv Rev"},{"key":"262_CR6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1128\/AAC.43.2.424","volume":"43","author":"T Kohler","year":"1999","unstructured":"Kohler T, Michea-Hamzehpour M, Epp SF, Pechere JC. Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems. Antimicrob Agents Chemother. 1999;43:424\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"262_CR7","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1128\/AAC.50.5.1633-1641.2006","volume":"50","author":"J Quale","year":"2006","unstructured":"Quale J, Bratu S, Gupta J, Landman D. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother. 2006;50:1633\u201341.","journal-title":"Antimicrob Agents Chemother"},{"key":"262_CR8","first-page":"303","volume":"16","author":"G Meletis","year":"2012","unstructured":"Meletis G, Exindari M, Vavatsi N, Sofianou D, Diza E. Mechanisms responsible for the emergence of carbapenem resistance in Pseudomonas aeruginosa. Hippokratia. 2012;16:303\u20137.","journal-title":"Hippokratia"},{"key":"262_CR9","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1128\/AEM.06513-11","volume":"78","author":"AN Brown","year":"2012","unstructured":"Brown AN, Smith K, Samuels TA, Lu J, Obare SO, Scott ME. Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus. Appl Environ Microbiol. 2012;78:2768\u201374.","journal-title":"Appl Environ Microbiol"},{"key":"262_CR10","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/jac\/dkn034","volume":"61","author":"D Roe","year":"2008","unstructured":"Roe D, Karandikar B, Bonn-Savage N, Gibbins B, Roullet JB. Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J Antimicrob Chemother. 2008;61:869\u201376.","journal-title":"J Antimicrob Chemother"},{"key":"262_CR11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2016.01.008","volume":"224","author":"H Zazo","year":"2016","unstructured":"Zazo H, Colino CI, Lanao JM. Current applications of nanoparticles in infectious diseases. J Control Release. 2016;224:86\u2013102.","journal-title":"J Control Release"},{"key":"262_CR12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/wnan.1211","volume":"5","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Tsai PC, Ramezanli T, Michniak-Kohn BB. Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013;5:205\u201318.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"262_CR13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-1-4939-0467-9_16","volume":"1147","author":"WS Cheow","year":"2014","unstructured":"Cheow WS, Hadinoto K. Antibiotic polymeric nanoparticles for biofilm-associated infection therapy. Methods Mol Biol. 2014;1147:227\u201338.","journal-title":"Methods Mol Biol"},{"key":"262_CR14","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.msec.2015.08.070","volume":"58","author":"M Samiei","year":"2016","unstructured":"Samiei M, Farjami A, Dizaj SM, Lotfipour F. Nanoparticles for antimicrobial purposes in Endodontics: a systematic review of in vitro studies. Mater Sci Eng C Mater Biol Appl. 2016;58:1269\u201378.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"262_CR15","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1039\/C3CC48130A","volume":"50","author":"D Hofmann","year":"2014","unstructured":"Hofmann D, Messerschmidt C, Bannwarth MB, Landfester K, Mailander V. Drug delivery without nanoparticle uptake: delivery by a kiss-and-run mechanism on the cell membrane. Chem Commun (Camb). 2014;50:1369\u201371.","journal-title":"Chem Commun (Camb)"},{"key":"262_CR16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bmcl.2006.09.098","volume":"17","author":"E Turos","year":"2007","unstructured":"Turos E, Shim JY, Wang Y, Greenhalgh K, Reddy GS, Dickey S, Lim DV. Antibiotic-conjugated polyacrylate nanoparticles: new opportunities for development of anti-MRSA agents. Bioorg Med Chem Lett. 2007;17:53\u20136.","journal-title":"Bioorg Med Chem Lett"},{"key":"262_CR17","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ijpharm.2016.09.078","volume":"513","author":"Y Fazli","year":"2016","unstructured":"Fazli Y, Shariatinia Z, Kohsari I, Azadmehr A, Pourmortazavi SM. A novel chitosan-polyethylene oxide nanofibrous mat designed for controlled co-release of hydrocortisone and imipenem\/cilastatin drugs. Int J Pharm. 2016;513:636\u201347.","journal-title":"Int J Pharm"},{"key":"262_CR18","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1039\/c2cs15327k","volume":"41","author":"M Elsabahy","year":"2012","unstructured":"Elsabahy M, Wooley KL. Design of polymeric nanoparticles for biomedical delivery applications. Chem Soc Rev. 2012;41:2545\u201361.","journal-title":"Chem Soc Rev"},{"key":"262_CR19","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1517\/17425247.2010.502560","volume":"7","author":"JW Rasmussen","year":"2010","unstructured":"Rasmussen JW, Martinez E, Louka P, Wingett DG. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expert Opin Drug Deliv. 2010;7:1063\u201377.","journal-title":"Expert Opin Drug Deliv"},{"key":"262_CR20","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jconrel.2014.03.055","volume":"190","author":"K Forier","year":"2014","unstructured":"Forier K, Raemdonck K, De Smedt SC, Demeester J, Coenye T, Braeckmans K. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms. J Control Release. 2014;190:607\u201323.","journal-title":"J Control Release"},{"key":"262_CR21","volume-title":"Bergey\u2019s manual of systematic bacteriology","author":"DH Bergey","year":"1989","unstructured":"Bergey DH, Krieg NR, Holt JG. Bergey\u2019s manual of systematic bacteriology. Baltimore: Williams and Wilkins; 1989."},{"key":"262_CR22","unstructured":"Institute CLS. Performance standards for antimicrobial susceptibility testing. In: Twenty-fifth informational supplement. Vol M100. Wayne: Clinical and Laboratory Standards Institute CLSI document M100-S25; 2015."},{"key":"262_CR23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2009.10.018","volume":"385","author":"CE Mora-Huertas","year":"2010","unstructured":"Mora-Huertas CE, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm. 2010;385:113\u201342.","journal-title":"Int J Pharm"},{"key":"262_CR24","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1128\/AAC.00033-10","volume":"54","author":"K Credito","year":"2010","unstructured":"Credito K, Kosowska-Shick K, Appelbaum PC. Mutant prevention concentrations of four carbapenems against gram-negative rods. Antimicrob Agents Chemother. 2010;54:2692\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"262_CR25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0167-7012(94)00062-C","volume":"22","author":"HR Barbosa","year":"1995","unstructured":"Barbosa HR, Rodrigues MFA, Campos CC, Chaves ME, Nunes I, Juliano Y, Novo NF. Counting of viable cluster-forming and non cluster-forming bacteria: a comparison between the drop and the spread methods. J Microbiol Methods. 1995;22:39\u201350.","journal-title":"J Microbiol Methods"},{"key":"262_CR26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12010-014-0852-z","volume":"173","author":"R Thomas","year":"2014","unstructured":"Thomas R, Nair AP, Kr S, Mathew J, Ek R. Antibacterial activity and synergistic effect of biosynthesized AgNPs with antibiotics against multidrug-resistant biofilm-forming coagulase-negative staphylococci isolated from clinical samples. Appl Biochem Biotechnol. 2014;173:449\u201360.","journal-title":"Appl Biochem Biotechnol"},{"key":"262_CR27","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/jam.12631","volume":"117","author":"SA El-Mowafy","year":"2014","unstructured":"El-Mowafy SA, Shaaban MI, Abd EI Galil KH. Sodium ascorbate as a quorum sensing inhibitor of Pseudomonas aeruginosa. J Appl Microbiol. 2014;117:1388\u201399.","journal-title":"J Appl Microbiol"},{"key":"262_CR28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/2049936115621709","volume":"3","author":"G Meletis","year":"2016","unstructured":"Meletis G. Carbapenem resistance: overview of the problem and future perspectives. Ther Adv Infect Dis. 2016;3:15\u201321.","journal-title":"Ther Adv Infect Dis"},{"key":"262_CR29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0939-6411(03)00025-0","volume":"56","author":"E Melzer","year":"2003","unstructured":"Melzer E, Kreuter J, Daniels R. Ethylcellulose: a new type of emulsion stabilizer. Eur J Pharm Biopharm. 2003;56:23\u20137.","journal-title":"Eur J Pharm Biopharm"},{"key":"262_CR30","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jconrel.2005.10.028","volume":"110","author":"HI Chang","year":"2006","unstructured":"Chang HI, Perrie Y, Coombes AG. Delivery of the antibiotic gentamicin sulphate from precipitation castmatrices of polycaprolactone. J Control Release. 2006;110:414\u201321.","journal-title":"J Control Release."},{"key":"262_CR31","first-page":"3593","volume":"10","author":"I Yariv","year":"2015","unstructured":"Yariv I, Lipovsky A, Gedanken A, Lubart R, Fixler D. Enhanced pharmacological activity of vitamin B12 and penicillin as nanoparticles. Int J Nanomed. 2015;10:3593.","journal-title":"Int J Nanomed"},{"key":"262_CR32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1128\/AAC.30.3.343","volume":"30","author":"R Wise","year":"1986","unstructured":"Wise R. In vitro and pharmacokinetic properties of the carbapenems. Antimicrob Agents Chemother. 1986;30:343\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"262_CR33","doi-asserted-by":"crossref","first-page":"979648","DOI":"10.1155\/2014\/979648","volume":"2014","author":"E Dahdouh","year":"2014","unstructured":"Dahdouh E, Shoucair SH, Salem SE, Daoud Z. Mutant prevention concentrations of imipenem and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii. Sci World J. 2014;2014:979648.","journal-title":"Sci World J."},{"key":"262_CR34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijmm.2011.10.001","volume":"302","author":"H Li","year":"2012","unstructured":"Li H, Luo YF, Williams BJ, Blackwell TS, Xie CM. Structure and function of OprD protein in PseudoImonas aeruginosa: from antibiotic resistance to novel therapies. Int J Med Microbiol. 2012;302:63\u20138.","journal-title":"Int J Med Microbiol"},{"key":"262_CR35","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1128\/AAC.44.4.891-897.2000","volume":"44","author":"L Poirel","year":"2000","unstructured":"Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo J-D, Nordmann P. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-\u03b2-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 2000;44:891\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"262_CR36","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1099\/jmm.0.008094-0","volume":"58","author":"XD Wang","year":"2009","unstructured":"Wang XD, Cai JC, Zhou HW, Zhang R, Chen GX. Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency. J Med Microbiol. 2009;58:1196\u2013202.","journal-title":"J Med Microbiol"},{"key":"262_CR37","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/1469-0691.12719","volume":"20","author":"P Nordmann","year":"2014","unstructured":"Nordmann P, Poirel L. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect. 2014;20:821\u201330.","journal-title":"Clin Microbiol Infect"},{"key":"262_CR38","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.2147\/IJN.S44100","volume":"8","author":"RK Kasimanickam","year":"2013","unstructured":"Kasimanickam RK, Ranjan A, Asokan GV, Kasimanickam VR, Kastelic JP. Prevention and treatment of biofilms by hybrid- and nanotechnologies. Int J Nanomed. 2013;8:2809\u201319.","journal-title":"Int J Nanomed"},{"key":"262_CR39","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013006475","volume":"30","author":"DJ Hines","year":"2013","unstructured":"Hines DJ, Kaplan DL. Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights. Crit Rev Ther Drug Carrier Syst. 2013;30:257\u201376.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"262_CR40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2011.09.064","volume":"158","author":"TK Dash","year":"2012","unstructured":"Dash TK, Konkimalla VB. Poly-\u0190-caprolactone based formulations for drug delivery and tissue engineering: a review. J Control Release. 2012;158:15\u201333.","journal-title":"J Control Release"},{"key":"262_CR41","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/j.ejmech.2008.09.045","volume":"44","author":"S Khoee","year":"2009","unstructured":"Khoee S, Yaghoobian M. An investigation into the role of surfactants in controlling particle size of polymeric nanocapsules containing penicillin-G in double emulsion. Eur J Med Chem. 2009;44:2392\u20139.","journal-title":"Eur J Med Chem"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-017-0262-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T18:06:59Z","timestamp":1569002819000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-017-0262-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,11]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["262"],"URL":"https:\/\/doi.org\/10.1186\/s12951-017-0262-9","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,11]]},"article-number":"29"}}